Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathway

European Journal of Cancer

Volumn 47, Issue 17, 2011, Pages 2654-2664

  Li, Wei ^a,b,c   Chen, Zheng ^a   Gong, Fei Ran ^b   Zong, Yang ^a   Chen, Kai ^c   Li, Dao Ming ^c   Yin, Hong ^c   Duan, Wei Ming ^c   Miao, Yi ^a   Tao, Min ^c   Han, Xiao ^b   Xu, Ze Kuan ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Akt; JNK; Pancreatic cancer; PI3K; PKC; PP2A

Indexed keywords

CANTHARIDIN; OKADAIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE B; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PANCREAS CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CANTHARIDIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUCIFERASES; NERVE TISSUE PROTEINS; OKADAIC ACID; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; PROTEIN PHOSPHATASE 2; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 80755189937     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.08.014     Document Type: Article

References (36)

1. S.J. Wang, Y. Gao, and H. Chen Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo Cancer Lett 293 1 2010 99 108
2. D. Li, K. Xie, R. Wolff, and J.L. Abbruzzese Pancreatic cancer Lancet 363 9414 2004 1049 1057 (Pubitemid 38410779)
3. X. Guo, and Z. Cui Current diagnosis and treatment of pancreatic cancer in China Pancreas 31 1 2005 13 22 (Pubitemid 40911497)
4. N. Bardeesy, and R.A. DePinho Pancreatic cancer biology and genetics Nat Rev Cancer 2 12 2002 897 909 (Pubitemid 37328891)
5. T. Efferth, P.C. Li, V.S. Konkimalla, and B. Kaina From traditional Chinese medicine to rational cancer therapy Trends Mol Med 13 8 2007 353 361 (Pubitemid 47126989)
6. G.S. Wang Medical uses of mylabris in ancient China and recent studies J Ethnopharmacol 26 2 1989 147 162
7. W. Li, L. Xie, and Z. Chen Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2/M cell-cycle arrest and apoptosis Cancer Sci 101 5 2010 1226 1233
8. R.E. Honkanen Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A FEBS Lett 330 3 1993 283 286 (Pubitemid 23276340)
9. T.A. Millward, S. Zolnierowicz, and B.A. Hemmings Regulation of protein kinase cascades by protein phosphatase 2A Trends Biochem Sci 24 5 1999 186 191 (Pubitemid 29348452)
10. V. Janssens, J. Goris, and C. Van Hoof PP2A: the expected tumor suppressor Curr Opin Genet Dev 15 1 2005 34 41 (Pubitemid 40127629)
11. Y.J. Chen, C.D. Kuo, and Y.M. Tsai Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells Anticancer Drugs 19 1 2008 55 64
12. S. Schweyer, A. Bachem, and F. Bremmer Expression and function of protein phosphatase PP2A in malignant testicular germ cell tumours J Pathol 213 1 2007 72 81 (Pubitemid 47354568)
13. A.M. Mingo-Sion, P.M. Marietta, E. Koller, D.M. Wolf, and C.L. Van Den Berg Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells Oncogene 23 2 2004 596 604 (Pubitemid 38175015)
14. M. Wang, C. Atayar, and S. Rosati JNK is constitutively active in mantle cell lymphoma: cell cycle deregulation and polyploidy by JNK inhibitor SP600125 J Pathol 218 1 2009 95 103
15. Y. Miyamoto-Yamasaki, M. Yamasaki, H. Tachibana, and K. Yamada Induction of endoreduplication by a JNK inhibitor SP600125 in human lung carcinoma A 549 cells Cell Biol Int 31 12 2007 1501 1506 (Pubitemid 47610738)
16. O. Potapova, M. Gorospe, and R.H. Dougherty Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner Mol Cell Biol 20 5 2000 1713 1722 (Pubitemid 30100190)
17. O. Potapova, M. Gorospe, and F. Bost C-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells J Biol Chem 275 32 2000 24767 24775 (Pubitemid 30626580)
18. J.M. Kyriakis, and J. Avruch Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation Physiol Rev 81 2 2001 807 869 (Pubitemid 32267078)
19. T. Kajiguchi, K. Yamamoto, and S. Iida Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines Cancer Sci 97 6 2006 540 545 (Pubitemid 43811597)
20. F.R. Cross, E.A. Garber, D. Pellman, and H. Hanafusa A short sequence in the p60src N terminus is required for p60src myristylation and membrane association and for cell transformation Mol Cell Biol 4 9 1984 1834 1842 (Pubitemid 14008294)
21. Y. Yin, S. Wang, and Y. Sun JNK/AP-1 pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells Biomed Pharmacother 63 6 2009 429 435
22. J. Carmichael, W.G. DeGraff, A.F. Gazdar, J.D. Minna, and J.B. Mitchell Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing Cancer Res 47 4 1987 936 942 (Pubitemid 17027905)
23. I. Nicoletti, G. Migliorati, M.C. Pagliacci, F. Grignani, and C. Riccardi A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry J Immunol Methods 139 2 1991 271 279
24. W.A. Kues, M. Anger, and J.W. Carnwath Cell cycle synchronization of porcine fetal fibroblasts: effects of serum deprivation and reversible cell cycle inhibitors Biol Reprod 62 2 2000 412 419 (Pubitemid 30067344)
25. X. Zhang, W. Yong, and J. Lv Inhibition of forkhead box O1 protects pancreatic beta-cells against dexamethasone-induced dysfunction Endocrinology 150 9 2009 4065 4073
26. H.Y. Zhou, K.F. Wan, and C.K. Ip Hepatocyte growth factor enhances proteolysis and invasiveness of human nasopharyngeal cancer cells through activation of PI3K and JNK FEBS Lett 582 23-24 2008 3415 3422
27. P. Liu, H. Cheng, T.M. Roberts, and J.J. Zhao Targeting the phosphoinositide 3-kinase pathway in cancer Nat Rev Drug Discov 8 8 2009 627 644
28. Z.K. Xu, W.Y. Zhao, Y. Zhu, X. Han, and Y. Miao Activation of the phosphatidylinositol-3 kinase/Akt signaling pathway in a subset of pancreatic adenocarcinomas Gastroenterology 132 4 2007 437 438
29. J.A. Engelman Targeting PI3K signalling in cancer: opportunities, challenges and limitations Nat Rev Cancer 9 8 2009 550 562
30. G. Song, G. Ouyang, and S. Bao The activation of Akt/PKB signaling pathway and cell survival J Cell Mol Med 9 1 2005 59 71
31. S. Gao, A. Shah, Y.B. Oh, W.H. Park, and S.H. Kim Urotensin II stimulates high frequency-induced ANP secretion via PLC-PI 3K-PKC pathway Peptides 31 1 2010 164 169
32. W. Zhang, and H.T. Liu MAPK signal pathways in the regulation of cell proliferation in mammalian cells Cell Res 12 1 2002 9 18 (Pubitemid 135708299)
33. K.M. Ko, D.H. Mak, P.Y. Chiu, and M.K. Poon Pharmacological basis of 'Yang-invigoration' in Chinese medicine Trends Pharmacol Sci 25 1 2004 3 6 (Pubitemid 38076949)
34. M.S. Dai, Y. Jin, J.R. Gallegos, and H. Lu Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc Neoplasia 8 8 2006 630 644 (Pubitemid 44379790)
35. A.B. Pardee The Yang and Yin of cell proliferation: an overview J Cell Physiol Suppl Suppl. 5 1987 107 110
36. T. Hunter Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling Cell 80 2 1995 225 236